QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=04DD7945FFF6B66F9A7BC14DACB3FACA;jsessionid=F7A3657BF44808CE2671B996EC3873A1;jsessionid=C8C8AFD372EC1CA97E37E20E9AB9C29C;jsessionid=AF285EC9EDB7EF9B1E3005747BDDDC77;jsessionid=3081F73BC7C8F94BB4A6E61F7887E117;jsessionid=04994DDD1036F615CE88C64FC6B71A2E (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=04DD7945FFF6B66F9A7BC14DACB3FACA;jsessionid=F7A3657BF44808CE2671B996EC3873A1;jsessionid=C8C8AFD372EC1CA97E37E20E9AB9C29C;jsessionid=AF285EC9EDB7EF9B1E3005747BDDDC77;jsessionid=3081F73BC7C8F94BB4A6E61F7887E117;jsessionid=04994DDD1036F615CE88C64FC6B71A2E